Nutex Health, Inc. (NUTX)
USD 30.03
(-6.04%)
USD 30.03
(-6.04%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 34.77 Million USD | 158.5% |
| 2022 | 13.45 Million USD | -92.5% |
| 2021 | 179.28 Million USD | -33.99% |
| 2020 | 271.6 Million USD | 184.71% |
| 2019 | 95.39 Million USD | 328003.99% |
| 2018 | 29.07 Thousand USD | 105.69% |
| 2017 | -510.72 Thousand USD | -107874.63% |
| 2016 | -473.00 USD | 28.55% |
| 2015 | -662.00 USD | 0.0% |
| 2011 | 1.01 Million USD | 110.92% |
| 2010 | 483.18 Thousand USD | 284.85% |
| 2009 | 125.55 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 10.15 Million USD | -23.13% |
| 2024 Q2 | 22.56 Million USD | 122.12% |
| 2023 Q4 | 13.21 Million USD | 86.99% |
| 2023 Q1 | 4.84 Million USD | 814.11% |
| 2023 Q2 | 9.64 Million USD | 99.0% |
| 2023 Q3 | 7.06 Million USD | -26.75% |
| 2023 FY | 34.77 Million USD | 158.5% |
| 2022 Q2 | 4.99 Million USD | 190.9% |
| 2022 Q3 | -26.46 Million USD | -630.16% |
| 2022 FY | 13.45 Million USD | -92.5% |
| 2022 Q1 | 1.71 Million USD | 531.33% |
| 2022 Q4 | 530.32 Thousand USD | 102.0% |
| 2021 FY | 179.28 Million USD | -33.99% |
| 2021 Q2 | 29.13 Million USD | 6725.78% |
| 2021 Q4 | 271.84 Thousand USD | -99.64% |
| 2021 Q3 | 76 Million USD | 160.86% |
| 2021 Q1 | 426.87 Thousand USD | -99.6% |
| 2020 Q2 | 113.72 Thousand USD | -57.33% |
| 2020 Q4 | 105.66 Million USD | 75841.65% |
| 2020 FY | 271.6 Million USD | 184.71% |
| 2020 Q1 | 266.5 Thousand USD | -45.66% |
| 2020 Q3 | 139.13 Thousand USD | 22.34% |
| 2019 Q4 | 490.46 Thousand USD | 2688.0% |
| 2019 FY | 95.39 Million USD | 328003.99% |
| 2019 Q1 | 13.53 Thousand USD | 243.73% |
| 2019 Q3 | 17.59 Thousand USD | 22.28% |
| 2019 Q2 | 14.38 Thousand USD | 6.32% |
| 2018 Q1 | 12.12 Thousand USD | 101.22% |
| 2018 Q4 | -9415.00 USD | -163.84% |
| 2018 FY | 29.07 Thousand USD | 105.69% |
| 2018 Q3 | 14.74 Thousand USD | 26.92% |
| 2018 Q2 | 11.62 Thousand USD | -4.14% |
| 2017 Q2 | 19.02 Thousand USD | 0.0% |
| 2017 Q3 | 11.06 Thousand USD | -41.87% |
| 2017 FY | -510.72 Thousand USD | -107874.63% |
| 2017 Q4 | -991.67 Thousand USD | -9066.31% |
| 2016 FY | -473.00 USD | 28.55% |
| 2015 FY | -662.00 USD | 0.0% |
| 2011 Q4 | 262.42 Thousand USD | 19.72% |
| 2011 Q1 | 281.68 Thousand USD | 198.44% |
| 2011 Q2 | 255.84 Thousand USD | -9.17% |
| 2011 Q3 | 219.2 Thousand USD | -14.32% |
| 2011 FY | 1.01 Million USD | 110.92% |
| 2010 FY | 483.18 Thousand USD | 284.85% |
| 2010 Q4 | 94.38 Thousand USD | -21.0% |
| 2010 Q3 | 119.47 Thousand USD | -20.28% |
| 2010 Q1 | 119.47 Thousand USD | 0.0% |
| 2010 Q2 | 149.86 Thousand USD | 25.44% |
| 2009 FY | 125.55 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Inovalon Holdings, Inc. | 499.7 Million USD | 93.041% |
| GE HealthCare Technologies Inc. | 7.92 Billion USD | 99.561% |
| Sharecare, Inc. | 129.49 Million USD | 73.147% |
| Progyny, Inc. | 238.79 Million USD | 85.438% |
| Aclarion, Inc. | -324.00 USD | 10732868.827% |
| CareMax, Inc. | 13.9 Million USD | -150.156% |
| Simulations Plus, Inc. | 43.15 Million USD | 19.413% |
| CareCloud, Inc. | 46.24 Million USD | 24.8% |
| Forian Inc. | 15 Million USD | -131.761% |
| Bullfrog AI Holdings, Inc. Warrants | 59.8 Thousand USD | -58050.788% |
| Bullfrog AI Holdings, Inc. Common Stock | 59.8 Thousand USD | -58050.788% |
| Minerva Surgical, Inc. | 27.24 Million USD | -27.649% |
| Omnicell, Inc. | 499.92 Million USD | 93.044% |
| Definitive Healthcare Corp. | 203.93 Million USD | 82.948% |
| Zhongchao Inc. | 8.51 Million USD | -308.522% |
| Accolade, Inc. | 192.06 Million USD | 81.894% |
| Streamline Health Solutions, Inc. | 11.54 Million USD | -201.258% |
| Ontrak, Inc. | 8.8 Million USD | -295.161% |
| SOPHiA GENETICS SA | 42.91 Million USD | 18.966% |
| R1 RCM Inc. | 484.5 Million USD | 92.823% |
| Spok Holdings, Inc. | 112.2 Million USD | 69.009% |
| Privia Health Group, Inc. | 161.5 Million USD | 78.468% |
| EUDA Health Holdings Limited | 842.07 Thousand USD | -4029.581% |
| HeartBeam, Inc. | - USD | -Infinity% |
| GeneDx Holdings Corp. | 60.62 Million USD | 42.638% |
| TruBridge, Inc. | 163.56 Million USD | 78.74% |
| Renalytix Plc | 156 Thousand USD | -22191.135% |
| Sharecare, Inc. | 129.49 Million USD | 73.147% |
| Health Catalyst, Inc. | 131.83 Million USD | 73.623% |
| 10x Genomics, Inc. | 409.31 Million USD | 91.504% |
| GoodRx Holdings, Inc. | 683.34 Million USD | 94.911% |
| SCWorx Corp. | 1.26 Million USD | -2640.113% |
| Schrödinger, Inc. | 140.69 Million USD | 75.283% |
| HealthEquity, Inc. | 622.63 Million USD | 94.415% |
| HealthStream, Inc. | 184.04 Million USD | 81.105% |
| MSP Recovery, Inc. | 5.56 Million USD | -525.435% |
| Augmedix, Inc. | 21.52 Million USD | -61.545% |
| BrightSpring Health Services, Inc. Common Stock | 1.43 Billion USD | 97.575% |
| Ontrak, Inc. | 8.8 Million USD | -295.161% |
| SHL Telemedicine Ltd. | 25.26 Million USD | -37.66% |
| CareCloud, Inc. | 46.24 Million USD | 24.8% |
| Premier, Inc. | 840.73 Million USD | 95.864% |
| Certara, Inc. | 213.31 Million USD | 83.698% |
| GeneDx Holdings Corp. | 60.62 Million USD | 42.638% |
| OneMedNet Corporation | -127.9 Thousand USD | 27288.562% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 1.43 Billion USD | 97.575% |
| EUDA Health Holdings Limited | 842.07 Thousand USD | -4029.581% |
| HeartBeam, Inc. | - USD | -Infinity% |
| CareCloud, Inc. | 46.24 Million USD | 24.8% |
| Mangoceuticals, Inc. | 431.5 Thousand USD | -7958.885% |
| CareMax, Inc. | 13.9 Million USD | -150.156% |
| Healthcare Triangle, Inc. | 6.77 Million USD | -413.12% |
| National Research Corporation | 86.66 Million USD | 59.876% |
| Aclarion, Inc. | -324.00 USD | 10732868.827% |
| OptimizeRx Corporation | 42.89 Million USD | 18.941% |